Our model predicted tumor response to CRT with statistically significant accuracy, highlighting several subsets of features—including GLCM_subset 5, FOS Signal_subset 5, and All_subset 5—endowed with satisfactory performances (accuracy ≥ 0.8) (Table 2). The gene discussed is FOS; the disease is neoplasm.